Home  |  Contact

Cellosaurus LB33-MELA (CVCL_E933)

[Text version]
Cell line name LB33-MELA
Synonyms LB33-MEL.A
Accession CVCL_E933
Resource Identification Initiative To cite this cell line use: LB33-MELA (RRID:CVCL_E933)
Comments From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_E934 ! LB33-MELB
CVCL_ZG34 ! LB33-MELC
CVCL_ZG35 ! LB33-MELD
Sex of cell Female
Age at sampling 43Y
Category Cancer cell line
Publications

PubMed=7875194; DOI=10.1002/eji.1830250206
Lehmann F., Marchand M., Hainaut P., Pouillart P., Sastre X., Ikeda H., Boon T., Coulie P.G.
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.
Eur. J. Immunol. 25:340-347(1995)

PubMed=8566071; DOI=10.1002/eji.1830260135
Brichard V.G., Herman J., Van Pel A., Wildmann C., Gaugler B., Wolfel T., Boon T., Lethe B.
A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
Eur. J. Immunol. 26:224-230(1996)

Cross-references
Encyclopedic resources Wikidata; Q54902059
Entry history
Entry creation22-Oct-2012
Last entry update29-Jun-2023
Version number12